A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NDs / neurodegenerative diseases

[Related PubMed/MEDLINE]
Total Number of Papers: 114
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NDs  (>> Co-occurring Abbreviation)
Long Form:   neurodegenerative diseases
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Association between neurodegenerative diseases and pneumonia: a retrospective population-based study. aHR, CI
2019 Codelivery of Plasmid and Curcumin with Mesoporous Silica Nanoparticles for Promoting Neurite Outgrowth. MSN, ROS
2019 Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies. ROS
2019 Effects of Curcumin on Microglial Cells. AD, ALS, CNS, COX-2, HD, MS, PD
2019 NeuroMuscleDB: a Database of Genes Associated with Muscle Development, Neuromuscular Diseases, Ageing, and Neurodegeneration. NMDs
2019 New insights into the role of microRNAs and long noncoding RNAs in most common neurodegenerative diseases. AD, CNS, HD, lncRNAs, miRNAs, ncRNAs, PD
2019 Panoramic Visualization of Circulating MicroRNAs Across Neurodegenerative Diseases in Humans. AD, ALS, MS, PD
2019 Strategies for brain-targeting liposomal delivery of small hydrophobic molecules in the treatment of neurodegenerative diseases. AD, BBB, PD, SHMs
2019 The Neuroprotective Effect of Doxycycline on Neurodegenerative Diseases. DOXY
10  2019 The Role of PI3K/Akt and ERK in Neurodegenerative Disorders. ---
11  2019 Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration. LMP
12  2018 Adult-onset brain tumors and neurodegeneration: Are polyphenols protective? ---
13  2018 alpha-Synuclein Aggregates with beta-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects. AOC, RBCs
14  2018 alpha-Synuclein Heterocomplexes with beta-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity. Abeta1-42, HC, PD, RBCs
15  2018 Blood-Based Biomarker Screening with Agnostic Biological Definitions for an Accurate Diagnosis Within the Dimensional Spectrum of Neurodegenerative Diseases. AD, APMI-CP
16  2018 Cellular Receptors of Amyloid beta Oligomers (AbetaOs) in Alzheimer's Disease. AbetaOs, AD, NFTs
17  2018 Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases. AD, ALS, MS, MSA, NMO, PD
18  2018 Computer Aided Drug Design and its Application to the Development of Potential Drugs for Neurodegenerative Disorders. CADD
19  2018 Consent to Medical Procedures of Patients with Neurodegenerative Diseases: A Comparative Study of Legal Regulations in Selected European Countries and in the United States. AD, MCI
20  2018 Could a Common Mechanism of Protein Degradation Impairment Underlie Many Neurodegenerative Diseases? htt, UPS
21  2018 Decoding Common Features of Neurodegenerative Disorders: From Differentially Expressed Genes to Pathways. AD, ALS, DEG, FTD, PD, PPI
22  2018 Determination of Imaging Biomarkers to Decipher Disease Trajectories and Differential Diagnosis of Neurodegenerative Diseases (DIsease TreND). CDSS, LS-SVM, ROIs, SOM
23  2018 Dysregulation of Transcription Factors: A Key Culprit Behind Neurodegenerative Disorders. ---
24  2018 Herpes Simplex Virus Vectors for Gene Transfer to the Central Nervous System. HSV
25  2018 Macro roles for microRNAs in neurodegenerative diseases. ---
26  2018 Mitochondrial dynamics, a key executioner in neurodegenerative diseases. AD, ALS, ATP, HD, PD
27  2018 Nano-delivery systems for encapsulation of dietary polyphenols: An experimental approach for neurodegenerative diseases and brain tumors. ---
28  2018 Neuroprotective Role of Phytochemicals. AD, PD
29  2018 Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. ---
30  2018 Reprogramming energetic metabolism in Alzheimer's disease. AD
31  2018 Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders. ---
32  2018 Social Cognition Dysfunctions in Neurodegenerative Diseases: Neuroanatomical Correlates and Clinical Implications. bvFTD, ToM
33  2018 Targeting mTORs by omega-3 fatty acids: A possible novel therapeutic strategy for neurodegeneration? ALS, HD, mTOR, PUFAs
34  2018 The Role of Gene Editing in Neurodegenerative Diseases. CRISPR/CAS, TALENs, ZFNs
35  2018 Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms. GLUT, LDHA, MCT-1, PDH, PDK1, PKM2
36  2017 A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration Reveals New Mechanisms of Redox Homeostasis and NF-kappaB Signaling. MP, MS, mt
37  2017 Astrocyte hepcidin is a key factor in LPS-induced neuronal apoptosis. LPS
38  2017 Cerium oxide nanoparticles: a 'radical' approach to neurodegenerative disease treatment. CeONPs
39  2017 Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases. AD, ALS, AUC, 0.87, FTD, PD
40  2017 Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus. CI, HR, PD, T2DM
41  2017 Erythrocyte membrane in the evaluation of neurodegenerative disorders. NKA, SPTA
42  2017 Free radicals and polyphenols: The redox chemistry of neurodegenerative diseases. ---
43  2017 Immunotherapies for neurodegenerative diseases: current status and potential of plant-made biopharmaceuticals. ---
44  2017 Influence of physical exercise on beta-amyloid, alpha-synuclein and tau accumulation: an in vitro model of oxidative stress in human red blood cells. ATHL, RBCs, SED
45  2017 Melatonin enhances neural stem cell differentiation and engraftment by increasing mitochondrial function. NSCs
46  2017 MicroRNAs in glaucoma and neurodegenerative diseases. miRNAs, mRNA
47  2017 Mitochondria and neurodegenerative diseases: the promising role of nanotechnology in targeted drug delivery. ---
48  2017 Molecular changes in obese and depressive patients are similar to neurodegenerative disorders. FOXO1, FOXO3a, IL-1beta, qRT-PCR, Zn
49  2017 Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy. AD, NTs, p75NTR, PD, TNF, Trk
50  2017 Plants-Derived Neuroprotective Agents: Cutting the Cycle of Cell Death through Multiple Mechanisms. ---
51  2017 Potential biomarkers and novel pharmacological targets in protein aggregation-related neurodegenerative diseases. ---
52  2017 Redox-sensitive GFP to monitor oxidative stress in neurodegenerative diseases. AD, ALS, PD, roGFP
53  2017 Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders. BBB
54  2017 The Role of Gene Editing in Neurodegenerative Diseases. ---
55  2017 Traffic jams and the complex role of alpha-Synuclein aggregation in Parkinson disease. aSyn, PD
56  2017 Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases. AD, HSF-1, Hsp90, PD
57  2016 A systems pharmacology approach to decipher the mechanism of danggui-shaoyao-san decoction for the treatment of neurodegenerative diseases. DSS, TCM
58  2016 Azadiradione ameliorates polyglutamine expansion disease in Drosophila by potentiating DNA binding activity of heat shock factor 1. AZD, HSF1, SCA
59  2016 CaspNeuroD: a knowledgebase of predicted caspase cleavage sites in human proteins related to neurodegenerative diseases. APP, PTMs
60  2016 Coumarin: A Privileged Scaffold for the Design and Development of Antineurodegenerative Agents. ---
61  2016 Essential Oils May Lead alpha-Synuclein towards Toxic Fibrils Formation. BBB, M. communis, PD
62  2016 Genomic Characteristics of Genetic Creutzfeldt-Jakob Disease Patients with V180I Mutation and Associations with Other Neurodegenerative Disorders. gCJD, GO, IPDs, V180I, WGS
63  2016 Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma. AD, PD, TBIs
64  2016 Harnessing Cerebrospinal Fluid Biomarkers in Clinical Trials for Treating Alzheimer's and Parkinson's Diseases: Potential and Challenges. AD, CSF, DMT, PD
65  2016 Hydrogen peroxide-mediated induction of SOD1 gene transcription is independent from Nrf2 in a cellular model of neurodegeneration. ALS, OS, ROS, TFs
66  2016 Improving drug delivery technology for treating neurodegenerative diseases. BBB
67  2016 Opposite Interplay between PPAR Gamma and Canonical Wnt/Beta-Catenin Pathway in Amyotrophic Lateral Sclerosis. ALS, PPARgamma
68  2016 Optimization of Aryl Amides that Extend Survival in Prion-Infected Mice. 2-AMT
69  2016 Perspectives on Development and Regulation of Therapeutic Products for CED-Based Therapy of Neurodegenerative Diseases. BBB, CED
70  2016 Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases. CVDs, DM
71  2016 Precise assembly and regulation of 26S proteasome and correlation between proteasome dysfunction and neurodegenerative diseases. ---
72  2016 Recent prospective of surface engineered Nanoparticles in the management of Neurodegenerative disorders. BBB
73  2016 Sequestration of cellular interacting partners by protein aggregates: implication in a loss-of-function pathology. ---
74  2016 Transcriptional induction of the heat shock protein B8 mediates the clearance of misfolded proteins responsible for motor neuron diseases. FLTD, HTS
75  2015 Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers. AUC, CI, DOR, NLR, PLR, SROC
76  2015 Closing the gap between brain banks and proteomics to advance the study of neurodegenerative diseases. ---
77  2015 Corneal sensitivity and tear function in neurodegenerative diseases. AD, EP, FA, MS, PD, TBUT
78  2015 Mutational Spectrum Analysis of Neurodegenerative Diseases and Its Pathogenic Implication. ---
79  2015 Prediction of Metabolic Gene Biomarkers for Neurodegenerative Disease by an Integrated Network-Based Approach. HD, PD
80  2015 Systems biology of neurodegenerative diseases. ---
81  2015 Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases. AD, ATM, CNS, HD, PD
82  2015 TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model. ALS, FALS, FTLD, SP, TDP-43, TG
83  2015 Unsupervised learning based feature extraction for differential diagnosis of neurodegenerative diseases: A case study on early-stage diagnosis of Parkinson disease. KSOM, LS-SVM, PPMI
84  2014 A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank. CNS
85  2014 Network analysis of neurodegenerative disease highlights a role of Toll-like receptor signaling. PPI
86  2014 Plasma-Enabled Carbon Nanostructures for Early Diagnosis of Neurodegenerative Diseases. CNs
87  2014 Protective effects of bajijiasu in a rat model of Abeta₂₅₋₃₅-induced neurotoxicity. AD
88  2014 The discovery and development of new potential antioxidant agents for the treatment of neurodegenerative diseases. ---
89  2014 Vascular and extravascular distribution of the ATP-binding cassette transporters ABCB1 and ABCC1 in aged human brain and pituitary. ABC, BBB
90  2013 A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. AD, FTLD, miRNAs
91  2013 Biology and genetics of prions causing neurodegeneration. ---
92  2013 Impaired mitochondrial energy production and ABC transporter function-A crucial interconnection in dementing proteopathies of the brain. AD
93  2013 NeuroGeM, a knowledgebase of genetic modifiers in neurodegenerative diseases. ---
94  2013 The neurobiology of dysautonomia in Parkinson's disease. AD, ALS, HD, PD
95  2013 Viruses and neurodegeneration. CNS
96  2012 Brain drug delivery systems for neurodegenerative disorders. DDS
97  2012 Natural animal models of neurodegenerative protein misfolding diseases. ---
98  2012 Protein repertoire impact of Ubiquitin-Proteasome System impairment: insight into the protective role of beta-estradiol. 2-DE, ALP, NB, UPS
99  2012 QSAR and molecular docking techniques for the discovery of potent monoamine oxidase B inhibitors: computer-aided generation of new rasagiline bioisosteres. ANN, MAO-B, MDock, QSAR
100  2011 Brain iron metabolism and its perturbation in neurological diseases. ---